close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

2.420 +0.020 (+0.83%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
25 26 Next >
News headline image
Why Clover Health Stock Is Surging After Hours ↗
Clover Health Investments Corp (NASDAQ: CLOV) shares are trading higher in Monday's after-hours session after the company reported better-than-expected top-line results and reaffirmed guidance. 
Via Benzinga
News headline image
We Asked, You Answered: What Stock Would You Never Buy Again? ↗
Almost all traders have had that moment: A confident stock pick or strategy that backfires and leaves the investor with less money than they had before and vowing never to trade that stock again. 
Via Benzinga
News headline image
All Bets Are Off Whether Clover Health Stock Surges or Sinks From Here ↗
It's not for certain CLOV stock spikes after its upcoming earnings report, and a lot needs to happen for it to make a true price recovery. 
Via InvestorPlace
News headline image
Has Clover Health Finally Bottomed Out? ↗
Clover is delivering improved operational results. Management's better than expected guidance lends positive outlook to CLOV stock. 
Via InvestorPlace
News headline image
Clover Health’s Technology Is Great But With Dead Money ↗
CLOV Stock has great technology but may lack the financial strength to make it in the Medicare Advantage arena. 
Via InvestorPlace
News headline image
It’s Time for Clover Health to Think Outside the Box ↗
A possible revenue stream for Clover Health is their policyholder’s health data. Could that be a way to get CLOV stock out of its funk? 
Via InvestorPlace
News headline image
Don’t Buy CLOV Stock Ahead of Earnings Report ↗
CLOV stock doesn't look good because revenue increases don't trump its greater issues. Don't get in ahead of Q1 earnings. 
Via InvestorPlace
News headline image
Do Not Think of Clover Stock as a Bargain Yet ↗
Clover Health certainly has the potential, but it carries more risks. Avoid CLOV stock at the current level. 
Via InvestorPlace
News headline image
Clover Health Investments, Corp. (NASDAQ:CLOV) Investor Alert: Update in Lawsuit ↗
San Diego, CA -- (SBWIRE) -- 04/22/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Clover Health Investments, Corp.... 
Via SBWire
News headline image
The Clover Health Debate Will Likely Settle With a Bullish Victory ↗
The Clover Health debate is a fiery one and it won't settle except in hindsight. Meanwhile, the better opportunity in CLOV stock is upside. 
Via InvestorPlace
News headline image
Clover Health Stock Is No Longer a Meme Stock ↗
A lack of battleground interest and and Clover Health's improving business bode well for long-term CLOV stock investors. 
Via InvestorPlace
News headline image
Clover Health Stock May Rise As Millions Could Lose Health Coverage ↗
CLOV stock has been under heavy selling pressure, but brighter days should lie ahead as Clover Health offers insure-tech solutions. 
Via InvestorPlace
News headline image
Clover Stock’s Recovery Could Reverse in the Short-Term ↗
The rebound in growth stocks, not its fundamentals, has been what is fueling the steady rebound in the price of CLOV stock since March. 
Via InvestorPlace
News headline image
Clover Health Is Risky But Offers a Healthy Upside Ahead ↗
Clover Health's robust fourth quarter and upbeat guidance has improved the risk/reward opportunity of CLOV stock. 
Via InvestorPlace
News headline image
What’s So Special About Clover Health? ↗
As many underserved U.S. seniors seek affordable healthcare, CLOV stock is transforming an entire industry through data and technology. 
Via InvestorPlace
News headline image
Clover Health Stock’s Outlook Has Improved, but It’s Still a Sell ↗
Clover's profitability is improving but remains dismal, while it seems to lack competitive advantages. As a result, CLOV stock is a sell. 
Via InvestorPlace
News headline image
Clover Health Is in Need of a Break After Massive Upsurge This Past Month ↗
CLOV stock has seen positive momentum since its earnings release. Due to this, it may become a speculative investment again in the short run. 
Via InvestorPlace
News headline image
Clover Health Is in Dire Straits as Medical Costs Remain High ↗
Clover Health’s medical loss ratio is high. The company is losing money per $1 of revenue it makes. CLOV stock upside could be limited. 
Via InvestorPlace
News headline image
Clover Health Stock Will Be Your Lucky Four-Leaf Clover in 2022 ↗
CLOV stock is high-risk, but potentially also high-reward, as Clover Health rakes in the revenue and helps at-risk patients get healthcare. 
Via InvestorPlace
News headline image
Executives Buy Around $2M Of 5 Penny Stocks ↗
Crude oil futures traded higher by around 2% on Wednesday. Investors, meanwhile, focused on some notable insider trades When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
News headline image
7 Meme Stocks Still Making a Lot of Noise ↗
You may think the meme stocks trend is over, but these seven Reddit favorites are still receiving a lot of chatter online. 
Via InvestorPlace
News headline image
Sell Clover Health Stock in the Wake of Its Rally ↗
CLOV stock recently enjoyed a considerable relief rally. However, its fundamentals remain as poor as ever and its gains will be fleeting. 
Via InvestorPlace
News headline image
Benzinga's Daily Brief On Trending Tickers For March 11, 2022: Tesla, DTE Energy, Amazon And More ↗
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... 
Via Benzinga
News headline image
Clover Health: Praying to the Great Google ↗
Although CLOV stock is down, it still has institutional support. Its leaders have past ties to Google and a deal could help both companies. 
Via InvestorPlace
News headline image
Is Clover Stock a Buy Right Now? Its 160% Revenue Growth Says Yes. ↗
Off and on the price chart, CLOV stock is heading towards a better tomorrow and has much less to do with recent meme-driven news. 
Via InvestorPlace
News headline image
Benzinga's Daily Brief On Trending Tickers For March 9, 2022: Crude Oil ETN, ZIM Integrated Shipping Services, GameStop And More ↗
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Kala Pharmaceuticals (NASDAQ:KALA) stock rose 86.8% to $1.14 during Tuesday's regular session. The current volume of 2.6 million shares is 326.2% of Kala... 
Via Benzinga
News headline image
76 Biggest Movers From Yesterday ↗
Gainers Houston American Energy Corp. (NYSE: HUSA) surged 494.7% to close at $11.30 on Monday amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc... 
Via Benzinga
News headline image
Why Is Clover Health (CLOV) Stock Up Today? ↗
Clover Health is trading higher after director Chelsea Clinton disclosed a 100,000 share purchase. Who else is betting big on CLOV stock? 
Via InvestorPlace
News headline image
Which Former President's Child Is Buying Shares Of Clover Health? ↗
Clover Health Investments Corp (NASDAQ: CLOV) shares are surging Monday following insider buying from a prominent public figure. What Happened: According to a Form 4 filing ... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today